Researchers use CT, 3D printing to examine 400M-year-old fossil

Nicholas Leider | | Health Imaging | Artificial Intelligence

Medical imaging is on the cutting edge of technology—but scientists are using CT scans to learn more about the prehistoric.

Researchers have used CT scans to examine a 400-million-year-old fossil. According to 3DPrinting.com, a team from Australian National University took high-resolution CT scans of the fossil. They then made 3D prints to reassemble the jaw. The team could study grooves in the fossil where blood vessels once were. They were even able to determine the direction of blood flow in some major arteries, said Gavin Young with ANU.

Check out the full story and photos here:

3D Printing and CT Scanning Lead to New Discoveries About Ancient Fish

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Related Content

Generative AI increases efficiency, quality of radiology reports
FDA clears AI-assisted CCTA software that assesses plaques for signs of heart disease
AI beats standard regression models at predicting lung cancer risk
AI reduces CT lung cancer screening workload by nearly 80%
How AI and CCTA help heart teams plan ahead before PCI
5 steps for evaluating radiology AI applications

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.